Company: TVRD
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001558370-25-011562
Chunk: 16

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part II, Item 2U
Chunk 16
---
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On June 20, 2025, Tvardi issued 280 shares of its common stock to a former consultant for aggregate proceeds of $1,316 pursuant to the exercise of options with an exercise price of $4.70 per share under Legacy Tvardi’s 2018 Stock Incentive Plan. The issuance of such shares was exempt from registration under Rule 701 promulgated under Section 3(b) of the Securities Act.

​

Item 3. Defaults Upon Senior Securities

None.

​

Item 4. Mine Safety Disclosures

​

Not applicable.

​

Item 5. Other Information

​

None.

​

Item 6. Exhibits.

​

​​​​​​​​​​​​​Incorporated by ReferenceExhibitNo.​Description of Exhibit​Form​File No.​Exhibit No.​Date Filed​​​​​​​​​​​2.1‡    Agreement and Plan of Merger and Reorganization, dated as of December 17, 2024, by and among Cara Therapeutics, Inc., CT Convergence Merger Sub, Inc. and Tvardi Therapeutics, Inc.    8-K    001-36279    2.1    December 18, 2024​​​​​​​​​​​3.1​Amended and Restated Certificate of Incorporation.​8-K​001-36279​3.1​February 7, 2014​​​​​​​​​​​3.2​Amended and Restated Bylaws.​10-Q​001-36279​3.2​November 14, 2024​​​​​​​​​​​3.3​Certificate of Amendment to Amended and Restated Certificate of Incorporation.​8-K​001-36279​3.1​June 7, 2024​​​​​​​​​​​3.4​Certificate of Amendment to Amended and Restated Certificate of Incorporation.​8-K​001-36279​3.1​December 30, 2024​​​​​​​​​​​3.5​Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cara Therapeutics, Inc., dated April 15, 2025 (Stock Split Amendment).​8-K​001-36279​3.1​April 15, 2025​​​​​​​​​​​